We are live on
!
Find out more
Fayez Sarofim & Co Portfolio holdings
AUM
$39.1B
1-Year Est. Return
15.14%
This Fund
S&P 500
This Quarter
Est. Return
-1.71%
1 Year Est. Return
+15.14%
3 Year Est. Return
+57.14%
5 Year Est. Return
+86.44%
10 Year Est. Return
+281.86%
AUM
$39.1B
AUM Growth
-$2.58B
(-6.2%)
Cap. Flow
-$777M
Cap. Flow
% of AUM
-1.99%
Top 10 Holdings %
Top 10 Hldgs %
48.1%
Holding
304
New
7
Increased
61
Reduced
122
Closed
10
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Blackstone
BX
|
+$189M |
| 2 |
NVIDIA
NVDA
|
+$148M |
| 3 |
Meta Platforms (Facebook)
META
|
+$51.9M |
| 4 |
Spotify
SPOT
|
+$39.2M |
| 5 |
AbbVie
ABBV
|
+$38.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$391M |
| 2 |
Apple
AAPL
|
+$135M |
| 3 |
Broadridge
BR
|
+$99.4M |
| 4 |
CoStar Group
CSGP
|
+$97.2M |
| 5 |
Zoetis
ZTS
|
+$48.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.98% |
| 2 | Financials | 18.32% |
| 3 | Consumer Staples | 10.72% |
| 4 | Energy | 9.97% |
| 5 | Communication Services | 9.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
CVS Health
CVS
$137B
| $486K | ﹤0.01% |
6,773
| – | – |
|
227
NextEra Energy
NEE
$185B
| $485K | ﹤0.01% |
5,221
+36
| +0.7% | +$3.2K |
|
228
Halozyme
HALO
$9.23B
| $485K | ﹤0.01% |
7,500
| – | – |
|
229
General Mills
GIS
$20.3B
| $460K | ﹤0.01% |
12,367
-348
| -3% | -$15.1K |
|
230
Eagle Materials
EXP
$6.36B
| $459K | ﹤0.01% |
2,425
| – | – |
|
231
Palantir
PLTR
$317B
| $437K | ﹤0.01% |
2,988
| – | – |
|
232
KLA
KLAC
$278B
| $430K | ﹤0.01% |
2,920
| – | – |
|
233
American Electric Power
AEP
$71.9B
| $426K | ﹤0.01% |
3,250
| – | – |
|
234
Biogen
BIIB
$30.4B
| $422K | ﹤0.01% |
2,300
| – | – |
|
235
Fox Class A
FOXA
$24.2B
| $409K | ﹤0.01% |
7,003
| – | – |
|
236
Cintas
CTAS
$81.8B
| $407K | ﹤0.01% |
2,405
+189
| +9% | +$36.2K |
|
237
iShares Core MSCI Emerging Markets ETF
IEMG
$149B
| $405K | ﹤0.01% |
5,812
| – | – |
|
238
Northern Trust
NTRS
$34.2B
| $399K | ﹤0.01% |
2,858
| – | – |
|
239
iShares Russell 2000 Growth ETF
IWO
$14.7B
| $397K | ﹤0.01% |
1,264
-50
| -4% | -$16.6K |
|
240
CrowdStrike
CRWD
$207B
| $390K | ﹤0.01% |
4,000
| – | – |
|
241
Diamondback Energy
FANG
$55B
| $389K | ﹤0.01% |
1,965
+90
| +5% | +$15.3K |
|
242
Capital One
COF
$128B
| $388K | ﹤0.01% |
2,128
| – | – |
|
243
Alcon
ALC
$34.3B
| $388K | ﹤0.01% |
5,149
+130
| +3% | +$10.4K |
|
244
General Motors
GM
$68.6B
| $380K | ﹤0.01% |
5,097
| – | – |
|
245
United Rentals
URI
$65.5B
| $364K | ﹤0.01% |
500
| – | – |
|
246
Virginia National Bankshares
VABK
$250M
| $359K | ﹤0.01% |
9,402
| – | – |
|
247
Occidental Petroleum
OXY
$54.6B
| $354K | ﹤0.01% |
5,451
| – | – |
|
248
Netflix
NFLX
$290B
| $352K | ﹤0.01% |
3,666
-2,772
| -43% | -$244K |
|
249
Qualcomm
QCOM
$181B
| $350K | ﹤0.01% |
2,715
+65
| +2% | +$9.49K |
|
250
iShares Russell 2000 ETF
IWM
$82.2B
| $348K | ﹤0.01% |
1,403
| – | – |
|
Similar funds
HF
Fayez Sarofim & Co's Q1 2026 Portfolio in Review
As of Q1 2026, Fayez Sarofim & Co held 304 positions worth $39.1B, down 6.2% from $41.7B the previous quarter. Its ten largest holdings account for 48% of the portfolio.
Fayez Sarofim & Co's Q1 2026 filing shows 7 new, 61 increased, 122 reduced and 10 closed positions. Its largest new stake was Versant Media Group: 15,524 shares worth $575K. The largest sale was AstraZeneca, an estimated $391M.
By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 32% a quarter earlier, followed by Financials and Consumer Staples.
- Fayez Sarofim & Co's largest Q1 2026 buy was Versant Media Group: 15,524 shares worth $575K.
- Fayez Sarofim & Co added most to Blackstone in Q1 2026, an estimated $189M increase.
- Fayez Sarofim & Co's biggest Q1 2026 reduction was Apple, cutting an estimated $135M.
- Fayez Sarofim & Co fully exited AstraZeneca in Q1 2026, selling an estimated $391M.
- Fayez Sarofim & Co's ten largest holdings make up 48% of its $39.1B portfolio in Q1 2026.
- Fayez Sarofim & Co opened 7 new positions and closed 10 in Q1 2026.
- Fayez Sarofim & Co's portfolio value fell 6.2% quarter-over-quarter to $39.1B.
Based on Fayez Sarofim & Co's 13F filing for Q1 2026, filed 15 May 2026.